Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

387 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 387 results

Very early researchEnded earlyNCT03454243
What this trial is testing

Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT02197897
What this trial is testing

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Who this might be right for
Bladder Cancer
Baylor College of Medicine 15
Large-scale testing (Phase 3)Study completedNCT00003906
What this trial is testing

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
NSABP Foundation Inc 19,747
Large-scale testing (Phase 3)Study completedNCT00066690
What this trial is testing

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more
ETOP IBCSG Partners Foundation 3,066
Testing effectiveness (Phase 2)UnknownNCT04389580
What this trial is testing

Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

Who this might be right for
COVID-19
Kafrelsheikh University 160
Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Post-approval studies (Phase 4)Study completedNCT00537771
What this trial is testing

Liver Safety Under Upfront Arimidex vs Tamoxifen

Who this might be right for
Breast Cancer
AstraZeneca 384
Testing effectiveness (Phase 2)Study completedNCT05659563
What this trial is testing

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

Who this might be right for
Breast CancerBreast Cancer, Early-Onset
MedSIR 92
Large-scale testing (Phase 3)Study completedNCT00233610
What this trial is testing

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 180
Not applicableWithdrawnNCT01297231
What this trial is testing

Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT00973037
What this trial is testing

CYP2D6 Genotype on the Clinical Effect of Tamoxifen

Who this might be right for
Breast NeoplasmsTamoxifenGenotype+1 more
Korea University Anam Hospital 922
Testing effectiveness (Phase 2)Study completedNCT02584465
What this trial is testing

REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression

Who this might be right for
Ovarian Carcinoma
ARCAGY/ GINECO GROUP 68
Testing effectiveness (Phase 2)Ended earlyNCT01685255
What this trial is testing

The IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Who this might be right for
Ovarian CancerGenitourinary (GU) Tumors
Incyte Corporation 83
Post-approval studies (Phase 4)Study completedNCT00756717
What this trial is testing

Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Loyola University 22
Not applicableUnknownNCT02311647
What this trial is testing

Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients

Who this might be right for
Endometrial Receptivity Post Tamoxifen Exposure
Sheba Medical Center 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04997941
What this trial is testing

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

Who this might be right for
Premenopausal Breast CancerHormone Receptor-positive Breast Cancer
Seoul National University Hospital 238
Testing effectiveness (Phase 2)UnknownNCT01266213
What this trial is testing

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Who this might be right for
Metastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal
Samsung Medical Center 147
Post-approval studies (Phase 4)Study completedNCT00649090
What this trial is testing

Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 1,549
Testing effectiveness (Phase 2)Study completedNCT00031720
What this trial is testing

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Who this might be right for
Breast CancerHot FlashesHot Flushes
Alliance for Clinical Trials in Oncology 112
Testing effectiveness (Phase 2)Ended earlyNCT04190056
What this trial is testing

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
University of California, San Francisco 1
Next Page